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Up-regulation of MMP-2 and MMP-9 Leads to Degradation of Type IV
Collagen During Skeletal Muscle Reperfusion Injury; Protection by the
MMP Inhibitor, Doxycycline
D. M. Roach, R. A. Fitridge, P. E. Laws, S. H. Millard, A. Varelias and P. A. Cowled∗
Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia 5011
Objectives: to determine the role of matrix metalloproteinases, MMP-2 and MMP-9, in reperfusion injury following
skeletal muscle ischaemia and whether inhibition of MMPs by doxycycline protects against tissue damage.
Methods: rats were anaesthetised and a tourniquet applied to the proximal thigh to occlude blood flow. Four hours of
ischaemia was followed by reperfusion for 0, 4, 24 or 72 h. Two further groups received doxycycline for 7 days prior to
bilateral ischaemia and 24 h reperfusion. Skeletal muscle from both limbs, kidneys and lungs were harvested for zymography
and immunohistochemical staining for type IV collagen.
Results: upregulation of MMP-2 and MMP-9 was detected by zymography in the ischaemic leg and lung but not in
the kidney. Quantitative immunohistochemical analysis showed marked degradation of type IV collagen in reperfused
muscle, lung and kidney. Doxycycline-treated rats showed significant preservation of type IV collagen in skeletal muscle
and a trend towards preservation in kidney and lung.
Conclusions: MMP-2 and MMP-9 are strongly upregulated in skeletal muscle ischaemia/reperfusion injury and are
also upregulated in remote organs, leading to degradation of basement membranes. Inhibition of MMP activity may
therefore be potentially therapeutically useful in reducing the severity of reperfusion injury.
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Introduction degrade all components of the extracellular matrix.
Together with their inhibitors, the tissue inhibitors of
metalloproteinases (TIMPs), they are the major physio-Lower extremity revascularisation, particularly fol-
logical regulators of the turnover of the extracellularlowing lengthy periods of profound ischaemia, fre-
matrix (reviewed in 9). Previous work from one of thequently results in exacerbation of the injury to the
current authors10 has demonstrated that these extra-limb as well as remote organ dysfunction. Reperfusion
cellular antigens disappear during ischaemia and re-injury and remote systemic effects vary and the bio-
perfusion, with a consequent loss of microvascularchemical and molecular mechanisms mediating this
integrity. Studies by Rosenberg and co-workers11 dem-damage remain unclear.
onstrated that focal ischaemia in the brain inducedA number of mechanisms of damage have already
the production and activation of MMPs -2 and -9,been implicated in skeletal muscle reperfusion injury,
suggesting a causative role for MMPs -2 and -9 inincluding complement activation and deposition,1,2
the vasculogenic oedema that accompanies cerebralgeneration and activity of reactive oxygen species,3
infarction. MMP-9 was expressed as an early eventincreased microvascular permeability4 and an increase
following permanent ischaemia in the mouse brain,in intracellular calcium,5 which can activate Ca2+-
correlating with the opening of the blood-brain bar-dependent proteases, leading to cellular injury. Ac-
rier.12 Similarly, in a model of transient ischaemiativation of leukocytes, which adhere to the endo-
and reperfusion in the mouse brain, Fujimura andthelium and infiltrate the surrounding tissues, also
colleagues demonstrated induction of both MMP-2plays a vital role in the induction of tissue damage.6–8
and MMP-9, also correlating with opening of theThe matrix metalloproteinases (MMPs) are a family
blood-brain barrier.13 The therapeutic utility of thisof zinc-dependent enzymes that have the ability to
knowledge was demonstrated in a rat model of focal
stroke where inhibition of MMPs by an MMP-9-neut-
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ralising antibody resulted in a reduction in infarctSurgery, The University of Adelaide, The Queen Elizabeth Hospital,
Woodville, South Australia 5011. volume.14 Similarly, inhibition of MMPs by doxycycline
1078–5884/02/030260+10 $35.00/0  2002 Elsevier Science Ltd. All rights reserved.
MMPs in Skeletal Muscle Reperfusion Injury 261
also significantly reduced infarct size in rats subjected Zymography
to reversible middle cerebral artery occlusion.15
The current study was therefore designed to deter- Gelatin zymography was carried out using a modi-
fication of the method of Porter et al.16 Fresh tissuemine whether MMPs -2 and-9 were activated during
skeletal muscle reperfusion injury, both in the re- was homogenised in lysis buffer (0.1 mM PMSF, 50 mM
Tris HCl (pH 7.6), 2 M Urea, 0.1% NaCl, 0.1% EDTA,perfused muscle and in distant organs involved in
multi-system failure. Having demonstrated this, ex- 0.1% Brij 35 (Sigma Aldrich, St Louis, MO, U.S.A.) and
the supernatant dialysed overnight in a Membra-Celperiments were then performed to test the therapeutic
efficacy of inhibiting MMP activity using doxycycline MD25-14 dialysis membrane (14 000 kDa cut-off)
against 25 mM Tris HCl (pH 8.5), 10 mM CaCl2, 0.1%in reducing the pathological effects of reperfusion
injury. Brij 35 and 0.1 mM PMSF. Protein concentration was
determined using a Bradford assay according to the
manufacturer’s instructions (BioRad, Hercules, CA,
U.S.A.). Cellular extracts (40 g total protein/lane)
Materials and Methods were electrophoresed through 10% non-reducing poly-
acrylamide gels containing 0.1% gelatin (Sigma Al-
Rat model of ischaemia and reperfusion in skeletal muscle drich). Gels were then incubated for 15–18 h at 37 ° in
of the hind limb zymogram buffer (Tris HCl, pH 7.5, 200 mM NaCl,
5 mM CaCl2, 0.02% Brij 35) to allow development of
A rat model of skeletal muscle ischaemia and re- gelatinolytic activity before being stained with Co-
perfusion has previously been established in our omassie Brilliant Blue R (Sigma Aldrich). Zymograms
laboratory.8 In brief, Sprague–Dawley rats (250–280 g; were assessed descriptively without any quantitation
5 rats/treatment) were anaesthetised by inhalation of of bands.
halothane and oxygen. The area over the thigh was
shaved, a photoplethysmography probe attached to
the skin over the femoral artery and blood flow mon-
itored on a Doppler ultrasound machine (Parks Med- Western blotting
ical Electronics; Aloha, Oregon, U.S.A.). To induce
ischaemia, a tourniquet of cotton tape was tied tightly Protein samples (40 g protein/lane) were elec-
around the proximal thigh of the rat. Ischaemia was trophoresed under reducing conditions through a 10%
considered to be adequate if the Doppler trace re- polyacrylamide gel and then transferred to Hybond
mained flat and was maintained for 4 h before the ECL membranes (Amersham Biosciences, Little
tourniquet was released and the return of blood flow Chalfont, Buckinghamshire, U.K.) by electrotransfer
to the limb monitored by the return of the Doppler in 25 mM Trizma base, 192 mM glycine 10% methanol,
trace. To control for the effects of anaesthesia, sham- pH 8.3. Membranes were blocked in 5% skim milk
operated rats were treated identically to the ischaemic powder in phosphate-buffered saline (PBS) before
rats, except the tourniquet was not applied to the overnight incubation in a 1/2000 dilution of a poly-
leg. Rats tolerated both the ischaemia and subsequent clonal rabbit anti-rat MMP-9 antibody (Chemicon, cat
reperfusion well with no mortalities. The Animal Eth- no AB19016, Temecula, Ca, U.S.A.). Secondary de-
ics Committees of the Queen Elizabeth Hospital and tection was carried out with a 1/1000 dilution of a
the University of Adelaide approved all experimental perixodase-labelled anti-rabbit IgG antibody (Dako
procedures used in this study. Australia, Botany, NSW) and ECL reagents (Amersham
Reperfusion was allowed to proceed for 0, 24 or Biosciences) according to the manufacturer’s in-
72 h before rats were sacrificed. A transverse block of structions. An MMP control-1 standard (Sigma Al-
skeletal muscle from both legs, containing all the drich) was also analysed on the blots to verify the
muscles of the calf, was harvested distal to the tour- identity of the immunoreactive bands.
niquet.8 Tissue crushed by the tourniquet was excluded
from analysis. Lungs and kidneys were also collected.
Tissues were either processed fresh for zymography,
snap-frozen in liquid nitrogen or fixed in 10% buffered Immunohistochemical analysis of degradation of type IV
collagenformalin. In a second series of experiments, ischaemia
was induced for 4 h in both legs of the rats followed
Frozen sections (10 M, skeletal muscle; 3 M, lung;by 0, 4 or 24 h reperfusion (5 rats/group) before tissues
were collected for analysis. 5 M, kidney) were fixed in 20% acetone at −20 ° for
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20 min, then incubated 3 times for 5 min in 0.1% bovine Statistical analysis
serum albumin (BSA) in PBS to block non-specific
binding. Sections were incubated for 15 h at 4 ° with In pilot experiments (data not shown), it was de-
termined the cumulative mean brightness measure-a 1/100 dilution of rabbit polyclonal anti-human type
IV collagen antibody (Rockland; Gilbertsville, PA, ment became stable when approximately 25 images
had been collected. It was therefore decided to collectU.S.A.) in 0.1% BSA/PBS. A slide from which the
primary antibody was omitted was included in all 35 measurements per slide, providing a total of 175
measurements of brightness of collagen immuno-experiments as a negative control. After washing 3
times in 0.1% BSA/PBS, sections were incubated for staining for each group of 5 rats. Further preliminary
analysis demonstrated that these measurements of1 h at room temperature with a 1/400 dilution in
0.1% BSA/PBS of biotinylated anti-rabbit IgG antibody brightness for each group of rats were normally dis-
tributed, therefore data were displayed using mean±1(Vector Laboratories; Burlingame, CA, U.S.A.). Sec-
tions were then incubated for 1 h at room temperature standard deviation. Data were then analysed using an
unbalanced 2-way ANOVA 3×4 factorial design withwith a 1/200 dilution in 0.1% BSA/PBS, of fluorescein-
conjugated streptavidin (Amersham Biosciences), interaction with p values of <0.05 considered sig-
nificant.washed and mounted under fluorescent mounting
medium (Dako, Australia). Tissues were examined Median scores for the degree of histological damage
in reperfused tissues were ranked and analysed usingusing an Olympus BH2 fluorescence microscope with
maximum excitation wavelength of 494 nm and max- analysis of variance. A p value of <0.05 was considered
significant.imum emission wavelength of 518 nm.
Thirty-five images were captured from each slide (1
slide/tissue sample) in a stepwise fashion across the
section, excluding the outside of the section to avoid
Resultsartefactual edge effects. Quantitation of type IV col-
lagen was carried out using VideoPro⊂ 4 software by
Zymographic detection of gelatinolytic activitymeasuring “brightness”, which is a function of both
pixel number and area. All comparisons between treat-
Figure 1 illustrates the induction of zymographic ac-ment protocols were carried out within the one ex-
tivity of MMP-2 and MMP-9 in tissues harvested fromperiment to avoid inter-experimental variation.
rats. Baseline low levels of the pro-form of MMP-2
(72 kDa) were observed in the skeletal muscle of sham-
operated rats but there was no MMP-9 activity in these
tissues (Fig. 1A). A similar result was observed when
the limbs were subjected to 4 h ischaemia only withoutHistological scoring of the degree of tissue damage
reperfusion. However, when the rats were subjected
to 4, 24 or 72 h reperfusion, there was a markedParaffin sections were cut and stained with haema-
induction of activity of pro-MMP-9 (92–97 kDa) as welltoxylin and eosin using standard methods. Sections
as elevated levels of pro-MMP-2 (72 kDa). Skeletalwere scored for the degree of damage using a pub-
muscle from rats subjected to 72 h reperfusion alsolished scale of 1–1017 by an independent observer
showed a qualitative increase in the levels of theblinded to the nature of the specimens.
62 kDa active form of MMP-2 and a reduction in the
amount of MMP-9 activity when compared to 24 h
reperfusion.
Zymographic analysis of lung tissue (Fig. 1B) also
demonstrated increased gelatinolytic activity, althoughTherapeutic intervention with doxycycline
less marked. Sham-operated animals showed zymo-
graphic activity corresponding to both pro-MMP-2 andThe therapeutic efficacy of inhibition of MMP activity
in reducing the severity of reperfusion injury was MMP-9 with highest activity in the animals sacrificed
immediately after 4 h anaesthesia. Gelatinolytic ac-assessed using the MMP inhibitor, doxycycline.18 Rats
in groups of five were treated by twice-daily gavage tivity decreased as the interval between anaesthesia
and euthanasia increased, presumably reflecting re-with doxycycline (50 mg/kg or 200 mg/kg in 2 ml
water) for 7 days prior to the induction of 4 h ischaemia covery from anaesthetic damage. In animals subjected
to 4 h ischaemia and 0–72 h reperfusion, levels ofto both legs, followed by 24 h reperfusion. Tissues
were harvested and analysed as described above. MMP-2 and MMP-9 were elevated with shorter times
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Fig. 2. Rats in groups of five were subjected to 4 h unilateral or
bilateral hindlimb ischaemia followed by 24 h reperfusion before
tissues were harvested. One group of rats were given 50 mg/kg
doxycycline, twice daily by gavage, for 7 days before being subjectedFig. 1. Rats in groups of five were subjected to 4 h unilateral hindlimb
to 4 h bilateral ischaemia and 24 h reperfusion. Frozen sections wereischaemia followed by 0–72 h reperfusion. Sham-operated animals
stained with a rabbit antibody against human type IV collagen,were subjected to 4 h anaesthetic and euthanased 0–72 h later. Skel-
followed by secondary detection with biotin-labelled anti-rabbit IgGetal muscle, lungs and kidneys were harvested and analysed by
and FITC-streptavidin. Magnification: 200×. A: Skeletal muscle; B:gelatin zymography (40 g protein/lane). Panel A: Skeletal muscle
Lung; C: Kidney.from the ischaemic limb; panel B: Lung; panel C: Kidney; panel D:
Western blot analysis of levels of MMP-9 protein in tissues following
I/R. Track 1: MMP control-1; Track 2: skeletal muscle from sham-
operated rat; Track 3: skeletal muscle from rat subjected to 4 h Immunohistochemical detection of levels of type IV
ischaemia and 24 h reperfusion; Track 4: lung from sham-operated
collagenrat; Track 5: lung from rat subjected to 4 h ischaemia and 24 h
reperfusion.
Type IV collagen is one of the major substrates of the
proteolytic activity of MMP-219 and MMP-920 and also
forms a key component of the basement membrane.
The amount of degradation of type IV collagen was
therefore chosen as an indicator of the degree of
of reperfusion and had returned to lower levels fol- tissue damage induced by MMP activity in vivo during
lowing 72 h reperfusion. However, samples of renal reperfusion injury. Figure 2 shows representative im-
tissue only expressed baseline levels of pro-MMP-2, ages of immunohistochemical staining patterns for
which did not alter following ischaemia and re- type IV collagen in tissues subjected to 4 h ischaemia
perfusion (Fig. 1C). (unilateral or bilateral) and 24 h reperfusion when
Western blotting (Fig. 1D) confirmed that levels of compared to sham-operated rats subjected to a 4 h
MMP-9 protein were elevated in skeletal muscle and anaesthetic and sacrificed 24 h later. There was a
lung tissues following 4 h ischaemia and 24 h re- marked reduction in the intensity of staining of the
perfusion. The identity of the gelatinolytic 92–97 kDa basement membrane in skeletal muscle, lungs and
band as MMP-9 was also confirmed by Western blot- kidney tissue following 4 h unilateral ischaemia and
ting when compared to a commercial MMP standard 24 h reperfusion. The degree of collagen breakdown
(Fig. 1D). Incubation of zymograms with the selective in all tissues was further increased when the rat was
zinc chelator, (1,10)-Phenanthroline (100 M), ab- subjected to a greater degree of ischaemia by having
olished all gelatinolytic activity (data not shown), both limbs occluded. Specificity of antibody binding
confirming the identity of these bands as metallo- was confirmed by omitting the primary antibody (data
not shown).proteinases.
Eur J Vasc Endovasc Surg Vol 23, March 2002
D. M. Roach et al.264
Fig. 4. Rats were subjected to either a sham-operation, 4 h unilateral
Fig. 3. Rats were subjected to 4 h bilateral ischaemia followed by 0, or bilateral ischaemia followed by 24 h reperfusion before tissues
4, 24 or 72 h reperfusion before tissues were harvested. Quantitative were harvested. Quantitative immunohistochemical analysis was
immunohistochemical analysis was carried out using VideoPro⊂ carried out using VideoPro⊂ software and the mean brightness
software and the mean brightness±1 standard deviation calculated. ±1 standard deviation calculated. Data were analysed using an
Data were analysed using an unbalanced 2-way ANOVA 3×4 unbalanced 2-way ANOVA 3×4 factorial design with interaction.
factorial design with interaction. ∗ p<0.05; ∗∗ p<0.01. ; Skeletal ∗ p<0.05; ∗∗ p<0.01. ; Skeletal muscle; Ε Lung; Φ Kidney.
muscle; Ε Lung; Φ Kidney.
Protection against reperfusion injury by doxycycline
Figure 3 illustrates the quantitation of the re-
lationship between the duration of reperfusion and an Effectiveness of prior treatment of the rats with doxy-
cycline before the induction of ischaemia and re-increasing loss of type IV collagen in tissues. Rats were
subjected to 4 h bilateral limb ischaemia followed by perfusion was assessed by determining if the type
IV collagen in the basement membranes in skeletalincreasing times of reperfusion from 0 h (ischaemia
only) to 72 h. The levels of type IV collagen decreased muscle, lungs and kidneys was protected from de-
gradation induced by reperfusion injury. The effect ofin all tissues with increasing duration of reperfusion,
although statistical significance (p<0.05) was only doxycycline treatment on the severity of reperfusion
injury was also assessed by gelatin zymography, andreached in the following two instances. The reduction
in collagen in the lungs was statistically significant by qualitative histological alterations in the degree of
injury to the muscle, lungs and kidneys.when comparing ischaemia plus 24 h reperfusion to
ischaemia only. Similarly, loss of type IV collagen Figure 5A illustrates qualitatively, the marked re-
duction in gelatinolytic activity of MMP-2 and MMP-was statistically highly significant in the kidney after
ischaemia plus 72 h reperfusion when compared to 9 in skeletal muscle following treatment of the rats
with doxycycline before 4 h bilateral ischaemia andthe ischaemia-only animals. A strong trend towards
degradation of type IV collagen in skeletal muscle was 24 h reperfusion. The gelatinolytic activity of MMP-9
was virtually abolished and the levels of both pro-also evident with increasing reperfusion times, but
did not reach statistical significance. Sham-operated MMP-2 and active MMP-2 were also reduced. The
lower dose of doxycycline (50 mg/kg) was sufficientanimals showed no change in the level of type IV
collagen with increasing times of survival following to inhibit gelatinolytic activity and increasing the dose
to 200 mg/kg did not cause a further decrease in4 h of anaesthesia (data not shown).
Figure 4 illustrates the increasing degree of collagen activity. In contrast, there was no detectable change
in MMP-2 and MMP-9 activity in lung tissue followingdegradation following 4 h ischaemia and 24 h re-
perfusion in all tissues tested when unilateral isch- administration of doxycycline (Fig. 5B). The levels of
gelatinolytic activity of pro-MMP-2 in the kidneys alsoaemia was compared to a greater ischaemic insult
which occurs when both legs were rendered ischaemic. did not change after doxycycline treatment (Fig. 5C).
Immunohistochemical staining for type IV collagenReductions in type IV collagen were statistically sig-
nificant (p<0.05) in both lungs and kidney when rats showed that administration of doxycycline partially
protected against collagen degradation. Figure 2subjected to unilateral ischaemia were compared to
sham-operated animals. A non-significant reduction (fourth column) illustrates staining of representative
tissue sections from animals pre-treated with 50 mg/in collagen levels in skeletal muscle was also noted.
Bilateral ischaemia also resulted in a greater reduction kg doxycycline compared to animals subjected to 4 h
ischaemia and 24 h reperfusion only. The intensity ofin collagen levels – though only statistically significant
in kidney. collagen staining in tissues from doxycycline-treated
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Fig. 5. Rats in groups of five were given 50 mg/kg or 200 mg/kg doxycycline twice daily by gavage for 7 days before being subjected to
4 h bilateral ischaemia and 24 h reperfusion. Tissues were harvested and analysed by gelatin zymography. Track 1: 4 h unilateral ischaemia/
24 h reperfusion; Track 2: 4 h bilateral ischaemia/24 h reperfusion; Track 3: 4 h bilateral ischaemia/24 h reperfusion plus 50 mg/kg
doxycycline; Track 4: 4 h bilateral ischaemia/24 h reperfusion plus 200 mg/kg doxycycline. Panel A: Skeletal muscle; panel B: Lung; panel
C: Kidney.
animals was brighter than in the animals subjected to haematoxylin and eosin-stained sections were graded
bilateral ischaemia and reperfusion only but collagen by an independent investigator according the criteria
staining did not return to the baseline intensity seen of Carter et al.17 Table 1 illustrates the median scores
in the sham-operated animals. Quantitation of bright- in tissues following 4 h bilateral ischaemia and 24 h
ness of staining is illustrated in Figure 6, which shows reperfusion and following pretreatment with either
statistically significant protection against collagen de- 50 mg/kg or 200 mg/kg doxycycline as described
gradation in the skeletal muscle of rats administered above. Figures in brackets represent the range of
50 mg/kg doxycycline (p<0.05). The higher dose of scores for the five rats in each treatment group.
doxycycline did not confer any additional protection When compared to the sham-operated animals, a
against collagen degradation, correlating with no highly significant increase in the degree of damage
change in the gelatinolytic activity of MMP-2 and was observed in both skeletal muscle (p=0.0044)
MMP-9 in skeletal muscle. Changes in the degree of and kidney (p<0.001) following 4 h bilateral ischaemia
brightness in lung and kidney tissues were less evident and 24 h reperfusion. Doxycycline (50 mg/kg) sig-
following doxycycline treatment. nificantly reduced the degree of I/R-induced damage
in kidney (p<0.05) but not in skeketal muscle. Lung
tissue showed a mild degree of damage in the sham-
operated rats, presumably reflecting injury causedHistological analysis
by 4 h of inhalational halothane anaesthesia and
the degree of gross pulmonary damage was notTo determine the degree of gross histological damage
significantly increased following ischaemia/re-following ischaemia/reperfusion (I/R) and to examine
whether doxycycline could reduce this damage, perfusion.
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Fig. 6. Rats in groups of five were given 50 mg/kg or 200 mg/kg doxycycline twice daily by gavage for 7 days, before being subjected to
4 h bilateral ischaemia and 24 h reperfusion. Tissues were then harvested and frozen sections immunostained for type IV collagen.
Quantitative immunohistochemical analysis was carried out using VideoPro⊂ software and the mean brightness ±1 standard deviation
calculated. Data were analysed using an unbalanced 2-way ANOVA 3×4 factorial design with interaction. ∗ p<0.05. ; Skeletal muscle;
Ε Lung; Φ Kidney.
Table 1. Paraffin sections were stained with haematoxylin and weights of the species observed, in accordance with
eosin and scored by an independent investigator blinded to the published sizes. The pro-form of MMP-2 (gelatinasenature of the treatment. Median scores plus, in brackets, the range
of scores, for each tissue (5 rats/group) are given in the table. A) is ubiquitously expressed and has a molecular
weight of 72 kDa, with an active form of 64 kDa.23,24 Pro-
Sham- Bilateral Doxycycline Doxycycline
MMP-9 has been widely reported as being 92–96 kDa25operated I/R 50 mg/kg 200 mg/kg
along with an 84 kDa activated form.26,27 Incubation of
Left leg 0 6.5 (4–7) 6 (4–6) 7 (6–7) zymograms with the zinc chelator, (1,10)-phenan-
Lung 2 (2–3) 3 (3–4) 3 (3–4) 3 (2–4)
throline, abolished all gelatinolytic activity, confirmingKidney 1 (0–1) 3 2 3 (2–3)
the identify of these bands as metalloproteinases. West-
ern blotting, using a commercially-available standard
for MMPs, also confirmed that the 92–96 kDa bandDiscussion
observed on the zymograms was MMP-9. Inter-
pretation of MMP levels in the zymograms was de-In the current study, we have shown that gelatinolytic
scriptive only and no quantitative analysis was carriedactivity corresponding to MMP-2 and MMP-9 is mark-
out.edly increased during ischaemia-reperfusion in a rat
Our data is in agreement with that reported bymodel of skeletal muscle lower limb occlusion. El-
Frisdal and co-workers who used a rat model ofevated activity of MMPs was observed both in the
permanent ligation of the femoral artery and dem-skeletal muscle that had undergone ischaemia and
onstrated an increase in gelatinolytic activity of MMP-2reperfusion and, to a lesser extent, in the lungs of
and MMP-9, accompanied by degradation of basementthese animals. However, zymographic activity in the
membrane components, including type IV collagenkidneys appeared unchanged. The increase in activity
and laminin in the soleus muscle.28 Although collateralof MMP-2 and MMP-9 correlated with a reduction in
circulation in the limb would provide some level ofbasement membranes of the levels of type IV collagen,
perfusion, ischaemia was permanent and there waswidely recognised as a major substrate for the pro-
no formal reperfusion phase in these studies. Thisteolytic activity of a number of the MMPs including
model is less relevant to the clinical situation and theyMMP-2 and MMP-9.19–22 The increase in gelatinolytic
were not able to examine mechanisms of damage toactivity also correlated with a marked increase in the
distant organs, which are also commonly affected inseverity of tissue damage as determine by histological
reperfusion injury.scoring, confirming the systemic nature of the isch-
The patterns of expression of MMP-2 and MMP-9aemic insult and demonstrating a similar pattern to
reported above are also in agreement with the resultsthe organ damage observed in the clinical situation.
of studies in both cerebral and cardiac ischaemia/The identity of the gelatinolytic activities observed
on the zymograms was defined by the molecular reperfusion (I/R). In an in vitro model of I/R in isolated
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rat hearts, reperfusion resulted in increased levels of infiltrating leukocytes are capable of secreting high
levels of MMP-9,36 confirming the elevation in gel-MMP-2 in the perfusate as well as in the ventricular
atinolytic activity observed on zymography.tissue. This rise in MMP-2 levels was partially inhibited
The molecular and cellular mechanisms which ac-by doxycycline, resulting in improved cardiac func-
tivate MMP-2 and MMP-9 during skeletal muscle re-tion.24 However, in an in vivo pig model of cardiac
perfusion injury remain to be elucidated. Elevatedischaemia (90 min) followed by brief reperfusion
levels of tissue MMP-9 are presumed to derive from(90 min), marked elevation of MMP activity was ob-
degranulation of infiltrating neutrophils, which are aserved but without degradation of collagen, pre-
major feature of reperfusion injury, both in the skeletalsumably a reflection of the brief duration of
muscle and in remote organs including the lungs.8 Thereperfusion.29 Increased levels of both collagenase
mechanisms inducing the elevated levels of MMP-2(MMP-1) and gelatinase (MMP-9) activity were also
and the nature of the cells which synthesise and secreteobserved following cardiac I/R in a pig model,30 with
MMP-2 are not yet clear. It has been reported thatMMP-9 immunolocalised to infiltrating leukocytes in
human skeletal muscle satellite cells in culture secretethe ischaemic myocardium.
MMP-2 and can also be induced to express MMP-9 byIn the kidney, despite considerable degradation of
treatment with phorbol ester.37 The MMP-2 promotertype IV collagen which was partially reversed by
contains a p53 consensus binding site and expressiondoxycycline (suggesting MMP involvement), no ac-
of p53 will cause transcriptional activation of MMP-tivation of gelatinolytic activity was evident following
2.38 Elevated levels of expression of p53 can be detectedI/R, although constitutive low levels of pro-MMP-2
during ischaemia/reperfusion,39 suggesting a possiblewere observed. This observation is in agreement with
mechanism which would result in the induction ofstudies by Jain and co-workers31 who showed that, in
elevated expression of MMP-2 in these tissues.a rat model of renal ischaemia/reperfusion, MMP-2
Other matrix metalloproteinases and their inhibitors,levels were only elevated very late (8 weeks after
the TIMPs, are also likely to participate in the cascade45 min of renal ischaemia) in the reperfusion phase. It
of events which leads to the induction of tissue damagetherefore appears likely that early renal collagen loss
during reperfusion injury. For example, the proteolyticobserved in the current study is mediated by MMPs
activity of MMP-3 has been implicated in the break-other than MMP-2 and MMP-9. Only very low levels
down of basement membrane proteins including la-of leukocyte infiltration were observed in kidneys of
minin and fibronectin as well as displaying somerats subjected to I/R, correlating with the absence of
proteolytic activity against type IV collagen.40 MMP-3zymographically-active MMP-9 in these tissues.
is also one of the primary activators of MMP-9 fromThe patterns of gelatinolytic activity observed in the its inactive proenzyme form41 which would make it
lungs are also consistent with published data reporting highly likely to play a role in tissue damage during
patterns of expression in various lung cell types. reperfusion injury. Other likely candidates include
Human bronchial epithelial cells secrete both 68 and MT1-MMP which is involved in a trimolecular cell
72 kDa forms of MMP-2 and 92 kDa MMP-9.32 Rat surface complex with both MMP-2 and TIMP-1, lead-
alveolar macrophages constitutively express MMP-233 ing to activation of MMP-2.42 Further investigations
as do lung fibroblasts, endothelial cells and vascular are required to delineate the pathways leading to
smooth muscle cells.34 All these MMP species were proteolytic damage of tissues during reperfusion in-
observed in the studies reported above, with an in- jury.
crease in MMP-9 activity following I/R, which cor- The above study has demonstrated that doxycycline
related with leukocyte infiltration into the tissues. was partially protective in reducing the degree of
Increases in lung MMP-2 and MMP-9 activity, along breakdown of type IV collagen, particularly in skeletal
with neutrophil migration into the tissues, were also muscle, but did not alter the degree of gross histo-
observed in lung transplantation models of I/R in the logical damage. Doxycycline is a broad-spectrum MMP
rat.35 inhibitor but has only moderate inhibitory activity.
The elevated activity of MMP-9 in damaged tissues, We observed a reduction in gelatinolytic activity and
demonstrated above, is in agreement with previous protection against type IV collagen breakdown but no
studies by ourselves8 and others, showing leukocyte significant reduction in the degree of tissue damage
infiltration during skeletal muscle reperfusion injury. observed by histological assessment. A clinically-
Schlag and co-workers demonstrated considerable ex- effective therapy is likely to involve blocking multiple
travasation of leukocytes into muscle tissue, which pathways leading to tissue damage, which will include
increased with increasing reperfusion times, and cor- MMP activation, complement deposition and ac-
tivation and neutrophil activation and adhesion.related closely with the degree of tissue injury.7 These
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